Orion Group Holdings, Inc.
NYSE:ORNEngineering & Construction
+$0.48 today
- Market cap
- $300.07M
- Beta
- 1.38
- P/E (TTM)
- 73.6
- EPS (TTM)
- $0.21
Volume 0.92M
Average 0.34M
ORN Net Change in Cash
Combined operating, investing, financing, and currency effects on the cash balance during the period.
Orion Group Holdings, Inc.NYSE: ORN
Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026
Net change in cash turns positive
Q1 FY2026 net change in cash was $4.67M, compared with -$15.36M a year earlier. Trailing-twelve-month net change in cash was -$5.01M. Over 3 fiscal years it compounded at +43.3% a year.
Context
- Net change in cash amounted to 2.9% of revenue in FY2025, up 2.6 pp from a year earlier.
- Net change in cash increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly net change in cash holds near $4.67M or moves back toward the trailing-twelve-month quarterly average of -$1.25M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Net Change in Cash history
USD · from the cash flow
- Latest · FY2025
- (25.03M) USD
- Year-over-year change
- -854.7%
| Period | Period end | Net Change in Cash | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (25.03M) | -854.7% |
| FY2024 | 2024-12-31 | (2.62M) | -109.7% |
| FY2023 | 2023-12-31 | 27.15M | +419.1% |
| FY2022 | 2022-12-31 | (8.51M) | -179.5% |
| FY2021 | 2021-12-31 | 10.7M | — |
Net Change in Cash vs competitors
How ORN compares with its peers on the latest reported figures
- Peers report in different currencies, so net change in cash is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -160.2% is the lowest of 10, against a peer median of +101.1%.
- Net change in cash amounts to 0.6% of revenue for ORN, versus a peer median of 0.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $56.87M USD | +277.8% | — | 77.6% | |
| LTM Mar 2026 | $47.48M USD | -59.0% | — | 5.6% | |
| LTM Feb 2026 | $32.43M USD | +122.2% | — | 8.3% | |
SRTAStrata Critical Medical, Inc. | LTM Mar 2026 | $23.3M USD | +1082.3% | -32.0% | 9.2% |
| LTM Mar 2026 | £10.19M GBP | — | — | — | |
| LTM Mar 2026 | $5.01M USD | -160.2% | +43.3% | 0.6% | |
| LTM Apr 2026 | $2.96M USD | +108.3% | — | 0.6% | |
| LTM Apr 2026 | $2.68M USD | -128.3% | -39.1% | 0.2% | |
| LTM Apr 2026 | $906K USD | -95.4% | — | 0.2% | |
| LTM Feb 2026 | $183K USD | +101.1% | -56.0% | 0.2% | |
| LTM Mar 2026 | $68K USD | +17.2% | -41.7% | 0.4% | |
| Peer median (excluding ORN) | — | +101.1% | -40.4% | 0.6% | |
Competitors are the stored peer set for ORN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (14.56M) | (12.61M) | (17.88M) | (1.64M) | 2.49M |
| Depreciation & Amortization | 30.53M | 28.87M | 30.64M | 32.73M | 21.94M |
| Deferred Income Tax | (9K) | 13K | (103K) | (27K) | 52K |
| Stock-Based Compensation | 2.4M | 2.75M | 2.04M | 4.01M | 5.45M |
| Change in Working Capital | (8.1M) | (5.24M) | 2.41M | (21.7M) | (8.56M) |
| Accounts Receivables | 8.46M | (44.03M) | (23.71M) | (850K) | (32.76M) |
| Inventory | 371K | (1.49M) | (729K) | (554K) | 787K |
| Accounts Payables | 589K | 39.37M | (4.51M) | 16.02M | 11.09M |
| Other Working Capital | (17.52M) | 910K | 31.36M | (36.31M) | 12.33M |
| Other Non-Cash Items | (10.2M) | (4.22M) | 61K | (689K) | 6.7M |
| Operating Cash Flow | 69K | 9.57M | 17.18M | 12.68M | 28.07M |
| Capital Expenditures | (16.98M) | (14.58M) | (8.91M) | (14.09M) | (38.86M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 27.6M | 4.88M | 11.08M | 2.61M | 25.16M |
| Investing Cash Flow | 10.63M | (9.7M) | 2.17M | (11.48M) | (13.7M) |
| Debt Repayment | 845K | (7.27M) | 14.84M | (30.26M) | (42.32M) |
| Common Stock Issued | 0 | 0 | 0 | 26.42M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (839K) | (1.1M) | (7.03M) | 25K | 2.93M |
| Financing Cash Flow | 6K | (8.37M) | 7.81M | (3.82M) | (39.39M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 10.7M | (8.51M) | 27.15M | (2.62M) | (25.03M) |
| Free Cash Flow | (16.91M) | (5.02M) | 8.27M | (1.42M) | (10.8M) |
Orion Group Holdings, Inc.
NYSE:ORN
Intrinsic Alpha fair value
Locked
Current Price
$7.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.